Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Non-cash Items (2022 - 2025)

CervoMed (CRVO) has disclosed Non-cash Items for 5 consecutive years, with $449540.0 as the latest value for Q2 2025.

  • Quarterly Non-cash Items rose 96.73% to $449540.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $449540.0 through Jun 2025, up 96.73% year-over-year, with the annual reading at $316560.0 for FY2024, 11.66% down from the prior year.
  • Non-cash Items hit $449540.0 in Q2 2025 for CervoMed, up from $228508.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $449540.0 in Q2 2025 to a low of $60688.0 in Q2 2022.
  • Historically, Non-cash Items has averaged $187430.7 across 4 years, with a median of $78533.0 in 2023.
  • Biggest five-year swings in Non-cash Items: grew 12.62% in 2023 and later soared 234.35% in 2024.
  • Year by year, Non-cash Items stood at $68062.0 in 2022, then soared by 426.49% to $358340.0 in 2023, then crashed by 36.23% to $228508.0 in 2024, then surged by 96.73% to $449540.0 in 2025.
  • Business Quant data shows Non-cash Items for CRVO at $449540.0 in Q2 2025, $228508.0 in Q2 2024, and $358340.0 in Q4 2023.